Columvi-10mg/10ml (Glofitamab-gxbm Vials) 10mg/10ml

Columvi (glofitamab-gxbm) 10mg/10ml is a prescription medication used in cancer therapy. This vial form supports targeted treatment protocols. Learn more about its uses, effects, and safety considerations for informed decisions.

Strength

10mg/10ml

Manufacturer / TM Owner

Roche Products Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Columvi (glofitamab-gxbm) 10mg/10ml is prescribed for certain types of cancer, including blood cancers. It belongs to a class of medications that work with the immune system to target cancer cells. Patients often ask, 'what is glofitamab used for' in oncology settings. This treatment is designed for use under medical supervision.

Side Effects

Like all medications, Columvi (glofitamab-gxbm) 10mg/10ml may cause effects such as fatigue, fever, or reactions at the injection site. Some users report mild to moderate symptoms during treatment. These effects vary by individual and are typically monitored by healthcare providers.

Precautions & Warnings

Columvi (glofitamab-gxbm) 10mg/10ml should be handled with care, as it is a potent medication. Patients should follow storage instructions and avoid exposure to extreme temperatures. Always consult a healthcare professional before starting or stopping treatment.

Avoid Interactions

Columvi (glofitamab-gxbm) 10mg/10ml may interact with other medications, including immunosuppressants or live vaccines. Alcohol and certain supplements could also affect its efficacy. Patients should disclose all current medications to their doctor to avoid potential interactions.

Frequently Asked Questions

Columvi (glofitamab-gxbm) is used to treat certain blood cancers by helping the immune system target cancer cells.

Columvi is given as an intravenous infusion under medical supervision in a clinical setting.

Common effects may include fatigue, fever, or reactions at the injection site.

Consult your doctor before combining Columvi with other treatments to avoid potential interactions.

Store Columvi vials as directed, avoiding extreme temperatures and direct sunlight.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.